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Dengue viruses (DENV) are members of the genus Flavivirus in the
family Flaviviridae. The four serotypes ofDENV (DENV1, DENV2,DENV3,
and DENV4) are the leading cause of arboviral diseases in the tropical
and subtropical regions.Whilemost DENV infections are asymptomatic,
somepeople presentwith adebilitating and self-limiteddisease, dengue
fever, or a severe and potentially life-threatening disease, dengue
hemorrhagic fever/dengue shock syndrome(Gubler, 2002;Guzmanand
Kouri, 2002; Halstead, 1988; WHO, 2009). DENV contains a positive-
sense, single-stranded RNA genome of about 10.6 kb in length. Flanked
by the 5′ and 3′ untranslated regions, the single open reading frame
encodes a polyprotein precursor, which is cleaved by cellular and viral
protease into three structural proteins, capsid (C), precursormembrane
(prM) and envelope (E), and seven nonstructural proteins, NS1, NS2A,
NS2B, NS3, NS4A, NS4B and NS5 (Lindenbach et al., 2007).After binding to its cellular receptor, DENV enters the cell through
receptor mediated endocytosis (Guirakhoo et al., 1993; Lindenbach
et al., 2007; Mukhopadhyay et al., 2005; Randolph and Stollar, 1990).
This is followed by uncoating, translation and genome replication.
Assembly occurs in the membrane of rough ER, where the immature
virions bud into the lumen of ER and transport through the secretary
pathway (Lindenbach et al., 2007; Mackenzie and Westaway, 2001;
Mukhopadhyay et al., 2005; Welsch et al., 2009). In the trans-Golgi,
cleavage of prM protein by furin or furin-like protease results in the
formation of mature virions, though the cleavage was inefﬁcient for
DENV (Keelapang et al., 2004; Murray et al., 1993; Stadler et al., 1997;
Wang et al., 1999; Yu et al., 2008). A unique property of ﬂaviviral
replication is the formation of subviral particles, which are smaller
and sediment slower than mature virions (Lindenbach et al., 2007;
Russell et al., 1980). Expression of both prM and E proteins can
produce recombinant virus-like particles (VLPs). VLPs are similar to
the infectious virions in the biophysical and antigenic features, though
some studies have shown that VLPs are more heterogeneous in size
than virions and not hemagglutinating in certain preparations
probably related to the efﬁciency of prM cleavage in different cells
(Allison et al., 2003; Ishikawa and Konishi, 2006; Junjhon et al., 2008;
Stadler et al., 1997; Wang et al., 1999). VLPs have been employed as a
model system to study the functions of prM/E proteins and assembly
of particles (Ferlenghi et al., 2001; Lorenz et al., 2003; Schalich et al.,
1996). Moreover, VLPs have been shown to be useful non-infectious
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et al., 2003;Davis et al., 2001;Hunt et al., 2001; Konishi and Fujii, 2002;
Kroeger and McMinn, 2002; Martin et al., 2007; Purdy et al., 2004).
The E protein is the major determinant of cellular tropism and
virulence, and the major target of neutralizing and enhancing
antibodies of DENV (Bray et al., 1998; Halstead, 1988; Lindenbach
et al., 2007; Mukhopadhyay et al., 2005). In the N-terminal
ectodomain of E protein, there are three well characterized domains
(domains I, II and III) based on X-ray crystallographic studies (Modis
et al., 2003, 2004, 2005). The C-terminus of E protein contains two
α-helices (EH1 and EH2) in the stem region and two transmembrane
domains (ET1 and ET2) in the anchor region, which crosses the two
leaﬂets of the lipid bilayer (Allison et al., 1999; Zhang et al., 2003)
(Fig. 1A). Based on the studies of the tick-borne encephalitis virus
(TBEV), both ET2 and ET1 were required for the assembly of E protein
into particles. EH2 can stabilize the prM–E heterodimer, whereas EH1
is involved in the irreversible trimerization of soluble E protein in low-
pH environment (Allison et al., 1999; Orlinger et al., 2006; Stiasny et al.,
1996). In addition, a study of the yellow fever virus reported thatFig. 1. Schematic drawing of the stem region of DENV4 prM protein, MH domain mutants,
contains an α-helical domain (MH) (residues 113 to 128) in the stem region, followed
designations of amino acids are shownwith numbers above indicating the amino acid positio
(B) Helical wheel analysis of the MH domain revealed an amphipathic helix with hydrophob
facing the other side. (C, D) At 48 h post-transfection, 293T cell lysates and pellets derived
analysis using human serum of a dengue case (Wang et al., 2006). (E) Transfected 293T cells
to 12% SDS-PAGE. The size of molecular weight markers is shown in kDa. One representativtransmembrane domains of prM and E proteins are involved in the
formation of VLPs (Op De Beeck et al., 2003).
The prM protein contains 166 amino acids, of which the cleavage
occurs at position 91 to produce the pr peptide and M protein. At the
C-terminus of prM protein, there is an α-helical domain (MH),
followed by two transmembrane domains (MT1 and MT2) (Fig. 1A)
(Zhang et al., 2003). After synthesis in the rough ER, prM protein
formed a heterodimer with E protein and was reported to function as
a chaperone for proper folding of E protein of TBEV and Japanese
encephalitis virus (JEV) (Konishi and Mason, 1993; Lorenz et al.,
2002). Recent cryo-electronic microscopic (EM) study of immature
DENV at low pH has provided new insights into the maturation of
DENV particles along the secretory pathway (Yu et al., 2008).
Moreover, a study of the crystal structure of recombinant prM–E
proteins complex revealed the heterodimeric interaction between the
N-terminus of prM protein (pr peptide, residues 1 to 81) and the E
protein ectodomain at high resolution, and predicted that the
extended part of M protein (residues 82 to 112) undergoes a large
conformational change during thematuration process (Li et al., 2008).production of VLPs and prM–E heterodimerization. (A) The C-terminus of prM protein
by two transmembrane domains (MT1 and MT2) (Zhang et al., 2003). Single letter
ns. The proline or alanine substitution mutants in the MH domain of pCB-D4 are shown.
ic residues at the a or d positions facing one side and charged or polar residues mainly
from culture supernatants of WT pCB-D4 or mutants were subjected to Western blot
were labeled with 35S-Met, immunoprecipitated with anti-E Mab FL0232 and subjected
e experiment of three is shown.
Fig. 2. Subcellular fractionation experiment of the MH domain mutants of DENV4 prM/E
construct. (A) 293T cells transfected with mock, WT or mutants were washed with PBS,
resuspended inmodiﬁed buffer B, and frozen–thawed 8 times (Hsieh et al., 2008; Xu et al.,
1997).After clearing thenuclei anddebris, themembrane fraction,pellets derived fromthe
soluble fraction by ultracentrifugation and pellets derived from culture supernatants were
subjected to Western blot analysis using human serum of a dengue case (upper gels)
(Wang et al., 2006), followed by reprobing with anti-calnexin Mab (lower gels). The long
exposure gels for prM bands in pellets were shown (middle gels). (B) Membrane fraction
and pellets of the soluble fraction of WT and mutants were treated with endo H (H) or
PNGase F (F), and subjected toWestern blot analysis as in panel A. Arrow heads indicate E
or deglycosylated E protein (Edg). The size of molecular weight markers is shown in kDa.
One representative experiment of three is shown.
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was reported to be involved in the prM–E interaction (Lin and Wu,
2005). Moreover, a histidine residue at position 39 of M protein
(position 130 of prM protein) of DENV2 and a tyrosine residue at
position 78 of prM protein of West Nile virus were reported to be
important for virus assembly (Pryor et al., 2004; Tan et al., 2009).
However, the functional roles of theMHdomain (residues 113 to 128) in
the replication cycle of DENV remain unknown. In this study, we
investigated the involvement of the MH domain of prM protein in the
assembly of VLPs by site-directed mutagenesis in the prM/E expression
constructs of DENV4, DENV1 and DENV2, and found that three proline
mutants at the C-terminus of MH domain severely impair the
production of VLPs. Thiswas further veriﬁed by examining the assembly
of DENV2 replicon particles and virions derived from a full-length
infectious clone. Moreover, two proline mutants were found to greatly
affect virus entry, suggesting that the C-terminus of MH domain is
involved in both assembly and entry of the DENV replication cycle.
Results
C-terminus of MH domain is involved in the production of DENV4 VLPs
Helical wheel analysis of the MH domain revealed an amphipathic
helix, in which hydrophobic residues at the a or d positions of the
wheel faced one side and charged or polar residues mainly faced the
other side (Fig. 1B). To investigate the roles of the MH helical domain
in the assembly of VLPs, site-directed mutagenesis was carried out to
replace each of the residues at the a or d positions (residues 113, 116,
120, 123 and 127) with a proline or alanine in a DENV4 prM/E
expression construct, pCB-D4 (Fig. 1A). Substitutions with proline, an
α-helix breaker, and alanine are commonly employed to study the
effect of disrupting helical structure and the effect of removing side
chain with helical structure preserved, respectively.
As shown in Fig. 1C, the amounts of prM/E proteins of the proline
mutants in cell lysates were generally comparable to those of wild
type (WT) pCB-D4, suggesting that substitutions of proline do not
greatly affect the expression of prM/E proteins. In contrast, the
amounts of prM/E proteins in pellets, compared to those of the WT,
were greatly reduced in mutants A120P, V123P and I127P and slightly
reduced in mutant A116P, suggesting that proline substitutions
introduced to residues 120, 123 and 127 at the C-terminus of the
MH domain, but not those at the N-terminus, greatly affect the
production of VLPs (Fig. 1C, long exposure for prM bands in pellets not
shown). Alanine substitutions introduced to two of these residues,
V123A and I127A, resulted in slightly reduced VLP production
(Fig. 1D). Of note, residues 116 and 120 are alanine themselves.
Other two alanine substitutions including S113A and H98A (H98A
was included in the analysis because its corresponding residue at
position 99 of JEV prM protein has been reported to be important for
prM–E interaction) did not affect VLP production (Lin andWu, 2005).
Together, these ﬁndings suggested that the C-terminus of the helical
structure is involved in production of VLPs of DENV4. To investigate
whether these mutations affect the prM–E interaction, lysates of 293T
cells transfected with each of these mutants were subjected to a
radioimmunoprecipitation assay using anti-EMab (Hsieh et al., 2008).
As shown in Fig. 1E, the amounts of prM protein relative to E protein
of these mutants, though slightly reduced for mutants V123P and
I127P, were generally comparable to that of the WT, suggesting that
alanine or proline substitutions introduced to the MH domain of
DENV4 do not greatly affect the prM–E heterodimeric interaction.
C-terminus of MH domain is involved in the production and release of
VLPs from the membrane to the lumen of ER
To further investigate whether the intracellular prM/E proteins of
these prolinemutants retain in themembrane-bound fraction or formVLPs in the soluble fraction of ER or other compartments, 293T cells
transfected with each of these proline mutants were subjected to a
previously described subcellular fractionation experiment (Hsieh
et al., 2008; Xu et al., 1997). As shown in Fig. 2A, the amounts of
prM/E proteins in pellets of the soluble fraction relative to those in the
membrane fraction were reduced for the proline mutants (A120P,
V123P and I127P) compared with those of the WT. Moreover, the
amounts of prM/E proteins in pellets of supernatants were much less
in these mutants than those in the WT. As a control, calnexin, an
integral ER membrane protein, was found in the membrane fraction
but not in the soluble fraction or supernatants. Enzyme digestion with
endo H or PNGase F of the membrane fraction and pellets of soluble
fraction revealed a predominantly endo-H sensitive pattern for both
WT and mutants (Fig. 2B), suggesting that intracellular prM/E
proteins of WT and mutants, either in the membrane-bound fraction
(before assembly to form VLPs) or in the soluble fraction (after
assembly), were mainly present in a compartment prior to trans-
Golgi, most likely ER. Collectively, these ﬁndings suggest that proline
substitutions introduced to the C-terminus of theMH domain result in
impairment in the production of VLPs from prM/E proteins in the
membrane of ER and release to the lumen and culture supernatants.
C-terminus of MH domain is involved in the production of VLPs of other
serotypes
To examine whether the C-terminus of the MH domain is also
involved in the production of VLPs of other DENV serotypes, proline
substitutions were introduced to residues 120I, 123V and 127A of the
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the DENV2 prM/E construct. In agreement with the ﬁndings in DENV4
mutants, the amounts of prM/E proteins in pellets relative to those in
cell lysates were greatly reduced in both DENV1 mutants (D1-I120P,
V123P and A127P) and DENV2mutants (D2-V120P, I123P and I127P),
when compared with the WT pCB-D1 and pCB-D2, respectively
(Figs. 3A and B). Radioimmunoprecipitation assay revealed that
amounts of prM protein relative to E protein of these mutants were
generally comparable to those of the WT (Fig. 3C). These ﬁndings
suggest that the C-terminus of the MH domain of DENV1 and DENV2
is also involved in the production of VLPs but not in the prM–E
heterodimerization.
C-terminal MH domain mutations affect the assembly and entry of
replicon particles
To further investigate the effects of the C-terminal MH domain
mutations on the assembly of replicon particles and infectivity, weFig. 3. Production of VLPs and prM–E heterodimerization of the MH domain mutants of
DENV1 and DENV2 prM/E constructs. (A, B) At 48 h post-transfection, 293T cell lysates
and pellets derived from culture supernatants of WT or mutants were subjected to
Western blot analysis using human serum of a dengue case (Wang et al., 2006). The
long exposure gels for DENV1 prM bands in pellets were shown below. (C) Transfected
293T cells were labeled with 35S-Met, immunoprecipitated with anti-E Mab FL0232 and
subjected to 12% SDS-PAGE. The size of molecular weight markers is shown in kDa. One
representative experiment of two is shown.employed a replicon particle packaging system, in which a DENV2
luciferase-reporting replicon was trans supplied with DENV2 WT or
mutant structural proteins (CprME) by sequential transfections
(Fig. 4A). Three mutant CprME constructs, of which each contained
a proline substitution at the C-terminus of the MH domain (A120P,
I123P and V127P) were generated. After the second transfection,
Western blot analysis revealed comparable amounts of E proteins in
the WT and mutants' packaging cells, suggesting that these MH
domain mutations do not affect the expression of E protein (Fig. 4B).
The luciferase activities detected in the mutants' packaging cells were
similar to that in the WT packaging cells, suggesting that these
mutations do not affect the replication of replicon RNA (Fig. 4C). To
monitor the amounts of packaged replicon particles in the culture
supernatants, we performed a real-time RT-PCR assay to quantify the
extracellular replicon RNA at 48 and 72 h post-transfection. As shown
in Fig. 4D, all three mutations signiﬁcantly reduced the amounts of
replicon RNA in the culture supernatants. Compared with that from
the WT packaging cells, the extracellular replicon RNA from mutants
A120A-, I123P- and V127P-packaging cells reduced by 87.3%, 96.7%
and 97.6%, respectively, at 72 h post-transfection. These ﬁndings
suggest that the C-terminal MH domainmutations affect the assembly
of replicon particles.
To examine the effect of these mutations on the infectivity of
replicon particles, which have been shown to be able to complete one-
round of replication (Jones et al., 2005; Pierson et al., 2006; Puig-
Basagoiti et al., 2005), we infected Vero cells with equal amounts of
WT and mutant replicon particles normalized by the amounts of
replicon RNA, and measured the luciferase activities in the target cells
at 48 h post-infection. As shown in Fig. 4E, the luciferase signals in the
mutant replicon particle A120P-, I123P-, and V127P-infected cells
were 29.7%, 0.16%, and 0.03%, respectively, of those of theWT replicon
particle-infected cells. Since these mutations were present on the
surface of replicon particles and did not affect the replication of
replicon RNA (Fig. 4C), the reduction of luciferase signals in the target
cells was most likely due to a defect in the entry of these MH domain
mutant particles.
C-terminal MH domain mutations affect the assembly and infectivity of
virions
To further investigate the involvement of the C-terminal MH
domain in the assembly and infectivity of virions, the three mutations
(A120P, I123P and V127P) were introduced to an infectious clone of
DENV2. After transfection to BHK-21 cells with equal amounts of RNA,
the numbers of positive cells detected by immunoﬂuorescence assay
(IFA) increased from 24 to 72 h in the cells transfected with WT RNA
(Fig. 5A). In contrast, the numbers of IFA-positive cells remained
similar from 24 to 72 h in the mutant I123P RNA- or V127P RNA-
transfected cells, suggesting no or limited spreading of virus in the
cultures. Mutant A120P RNA-transfected cells exhibited a slight
increase in IFA-positive cells over time. At 72 h, the IFA-positive
cells in the cells transfected with WT, A120P, I123P and V127P RNA
were 80%, 20%, 13% and 14%, respectively (calculated from three
random views under a microscope).
To examine the production of virions, pellets derived from culture
supernatants post-transfection were subjected to Western blot
analysis using anti-E Mab. Compared with that in the WT pellets,
the amount of E protein in pellets derived from these mutants was
greatly reduced with very faint band detected for mutants I123P and
V127P (Fig. 5B, upper panel). Consistent with this, the amount of viral
RNA in the culture supernatants (containing virions) of mutants
A120P, I123P and V127P was 1.8, 4.3 and 4.2 log, respectively, lower
than that of the WT (Fig. 5B, lower panel). Together, these results
suggest that all three MH domain mutants affect the assembly of
virions with greater impairment in mutants I123P and V127P than in
mutant A120P.
Fig. 4. Effects of MH domain mutations on the assembly and infectivity of replicon particles. (A) DENV2 replicon particles were prepared by sequential transfections of BHK-21 cells
with replicon RNA andWT or mutant CprME RNA. (B) At 30 h after the ﬁrst transfection, cells were examined for E protein expression byWestern blot analysis using anti-E Mab 4G2.
Host γ-tubulin protein was used as a loading control. (C) At 32, 48 and 72 h post-transfection, the luciferase activities in the transfected cells were measured. (D) Viral RNA extracted
from the culture supernatants (containing replicon particles) were quantiﬁed by real-time RT-PCR; the relative amounts of replicon RNA to that of theWT replicon RNA at 72 h post-
transfection (100%) are presented. (E) Equal amounts of WT and mutant replicon particles (normalized by RNA amounts) were inoculated to Vero cells. At 48 h, the luciferase
activities in the mutant-infected cells were measured; the luciferase signals relative to that of theWT-infected cells (100%) are shown. Data are mean and standard errors from three
independent experiments.
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natants collected from transfected cells (passage 0) and revealed
similar plaque sizes for WT, mutants I123P and V127P (Fig. 5C); the
plaque sizes of these viruses did not change after ﬁve rounds of
passages on Vero cells. Sequencing the entire CprME genes of the
passage 0 viruses of mutants I123P and V127P showed that the
engineered proline had been predominantly reverted to leucine and
low levels of the engineered proline were detected in both mutants,
possibly derived from the residual undegraded RNA after transfection.
The original proline mutations (I123P and V127P) were completely
reverted to leucine substitutions (I123L and V127L, respectively) in
the passage 5 viruses (Fig. 5D, middle and lower panels). These results
suggest that a reversion of proline to leucine at positions 123 and 127
is required to restore viral replication/infection.
In contrast to I123P and V127P mutants, the passage 0 virus of
A120P had heterogeneous plaque sizes with more small plaques than
large plaques; the passage 5 virus of this mutant showed more
homogeneous plaque sizes with predominant large plaques (Fig. 5C).
Sequencing the CprME genes of the passage 0 and 5 viruses of mutant
A120P revealed that the passage 0 virus retained the original
mutation (proline at position 120), whereas the passage 5 virus
displayed a mixed population (proline and leucine at position 120;
tryptophan and glycine at position 115) (Fig. 5D, upper panels),
suggesting that the original A120P mutation could be tolerated for
productive infection (though with reduced efﬁciency) and adaptive
mutations accumulated gradually.
Validation of V127L adaptation
Since only the CprME genes rather than complete genome were
sequenced, it is possible that in addition to the observed leucine
substitutions (123L and 127L) in the passage 5 viruses of mutants
I123P and V127P (Fig. 5D), other mutations outside the structural
genes may also contribute to the restored viral replication. To exclude
this possibility, we engineered V127L substitution into the WT
infectious cDNA clone. After transfection to BHK-21 cells with equalamounts of RNA, the numbers of IFA-positive cells increased from 24
to 72 h in both WT and V127L RNA-transfected cells (Fig. 6A),
suggesting rapid virus spreading in both cultures. This was in stark
contrast to the V127P RNA-transfected cells, which showed no virus
spreading (Fig. 5A). Themutant V127L virus exhibited plaque size and
morphology similar to those of the WT virus (Fig. 6B). Sequencing the
CprME genes revealed that the engineered mutation retained in
mutant virus V127L (Fig. 6C). Comparable viral titers were detected
for WT and mutant V127L viruses at various time points post-
transfection (Fig. 6D). These results suggest that a single amino acid
substitution from proline to leucine at position 127 of prM protein can
restore viral replication of mutant V127P.
Discussion
In this study, we used the approach of site-directed mutagenesis
and different functional assays to investigate the roles of the MH
domain of prM protein in the DENV replication cycle. Analysis of the
assembly of VLPs of DENV1, DENV2 and DENV4 suggested that proline
substitutions of three residues (120, 123 and 127) at the C-terminus
of MH domain greatly affected the amounts of VLPs detected in the
lumen of ER and in the culture supernatants. Due to the size
heterogeneity of VLPs, it is possible that some small VLPs might not
be sedimented through 20% sucrose cushion after ultracentrifugation
and thus be detected in the pellets. However, it has been shown in a
study of TBEV prM/E constructs that a sensitive four-layer ELISA
detected all the E protein in the pellets (presumably containing both
large and small sized VLPs) but not in the supernatants after
ultracentrifugation of the culture medium (Allison et al., 1999),
suggesting that the pelleting efﬁciency of heterogeneous VLPs is
unlikely to account for the less amounts of VLPs detected in the pellets
of mutant VLPs (presumably containing large and small sized VLPs as
well). The possibility that these mutations may affect the stability of
VLPs and thus the amounts of VLPs detected in the ER lumen and
culture supernatants could not be completely ruled out; it is worth
noting that the amounts of mutant prM/E proteins in the total cell
Fig. 5. Effects of MH domain mutations on the assembly and infectivity of virions. (A) BHK-21 cells were transfected with equal amounts (10 μg) of WT and mutant genome-length
RNA derived from a DENV2 infectious cDNA clone, and viral protein synthesis was analyzed by IFA at 24, 48 and 72 h post-transfection. Anti-EMab 4G2 and Alexa Fluor 488 goat anti-
mouse IgG were used as primary and secondary antibodies, respectively. (B) Pellets (containing virions) derived from ultracentrifugation of culture supernatants on day 5 post-
transfection were examined by Western blot analysis using anti-E Mab 4G2 (upper panel). The size of molecular weight markers is shown in kDa. Viral RNA extracted from the
culture supernatants (containing virions) were quantiﬁed by real-time RT-PCR; the relative amount of viral RNA of each mutant to that of WT virus (100%) is shown (lower panel).
(C) Plaque morphologies of WT and mutant viruses. Viruses collected on day 5 post-transfection (passage 0) were subjected to plaque assay in BHK-21 cells as described previously
(Poh et al., 2009). After ﬁve rounds of continuous culture on Vero cells, the passage 5 viruses were also subjected to plaque assay. (D) Sequencing chromatograms of viral RNA
extracted from culture supernatants of passage 0 and 5 viruses. The nucleotides and corresponding amino acids are indicated above the chromatogram peaks.
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and B), suggesting that the expression and stability of mutant prM/E
proteins in the cells were not greatly affected. Further pulse-chase
experiment is needed to address the stability of these mutant VLPs in
different fractions. Introducing these mutations to a DENV2 replicon
packaging system revealed that all three mutants affect the assembly
of replicon particles and two mutants greatly affect the entry.
Moreover, all three mutants affect the assembly and infectivity of
virions from a DENV2 infectious clone. To our knowledge, this is the
ﬁrst report demonstrating that the C-terminus of the MH domain of
prM protein plays an important role in both assembly and entry of
DENV, two important steps of the replication cycle.Characterization of the adaptive changes of these mutant viruses
provided interesting information regarding the structure and function
of the MH domain. After sequencing the entire CprME gene, all the
adaptive changes were found in the MH domain rather than in other
domains of the CprME proteins (Fig. 5D), suggesting that the MH
domain is probably structurally distinct. This is consistent with the
cryo-EM picture of the MH domain, which is close to and partially
buried in the membrane rather than interacting with the ectodomain
of E protein or other part of prM protein (Zhang et al., 2003). That all
adaptive changes contained substitutions to a hydrophobic but not a
non-hydrophobic residue suggests the importance of hydrophobic
residues tomaintain the helical structure of MH domain. Interestingly,
Fig. 6. Characterization of 127VL adaptation. (A) Analysis of viral protein synthesis in BHK-21 cells, which were transfected with equal amounts (10 μg) of WT and mutant V127L
genome-length RNA, by IFA at 24, 48 and 72 h post-transfection. Data are presented as in Fig. 5A. (B) Plaque morphologies of the WT and mutant V127L viruses collected on day 5
post-transfection (Poh et al., 2009). (C) Sequencing chromatograms of viral RNA extracted from culture supernatants ofWT andmutant V127L viruses on day 5 post-transfection. (D)
Production of theWT andmutant V127L viruses after RNA transfection. Viral titers (PFU/ml) in the culture supernatants collected every 24 h from days 1 to 5 post-transfection were
determined by plaque assay (Poh et al., 2009).
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tryptophan rather than to other hydrophobic residues such as
isoleucine, valine, methionine and phenylalanine. Analysis of the
codons revealed that the substitutions from proline to leucine (CCA to
CTA of residue 120, CCT to CTT of residue 123, and CCC to CTC of
residue 127) and from glycine to tryptophan (GGG to TGG of residue
115) involve only one nucleotide change, presumably the easiest and
quickest way to acquire viable adaptation, whereas substitutions to
other hydrophobic residues generally involve two or more nucleotide
changes (Table 1). Notably, the adaptive changes for mutants I123P
and V127P were found in the passage 0 viruses, suggesting that the
original proline mutations at these positions were not tolerated and
the adaptation occurred very rapidly (Fig. 5D). The observations that
introducing one substitution (V127L) to the WT infectious clone
completely restore virus replication of V127P (Figs. 6A and D) suggest
that a single amino acid adaptation from proline to leucine at position
127 is sufﬁcient. Compared with the severe impairment of VLPs
assembly by DENV4 mutant I127P, introducing leucine substitution at
position 127 in the DENV4 prM/E expression construct completely
restores the assembly of VLPs (data not shown).
On the other hand, the passage 0 virus of mutant A120P retained
the original proline mutation and the adaptive changes were found in
the passage 5 virus, suggesting that the original mutation was
tolerated for a productive but probably inefﬁcient replication, as
was evidenced by the predominant small sized plaques in the passage
0 virus (Fig. 5C). The appearance of predominant large sized plaques
in the passage 5 virus, which coincided with the adaptive changes of
tryptophan over glycine at position 115, may suggest gradual
adaptation to more efﬁcient replication. Whether the large plaques
in the passage 5 virus contain tryptophan substitution at position 115
and the small plaques in the passage 0 virus contain the original
proline mutation at position 120 remain to be veriﬁed by sequencing
each plaque-puriﬁed virus.By studying VLPs, packaging of replicon particles and virions
production, we showed that the C-terminus rather than theN-terminus
of theMH domain is involved in the assembly. Cryo-EM study of DENV2
virions revealed that the C-terminus of the MH domain as well as the
EH1 and EH2 domains of E protein is partially buried in the outer leaﬂet
of viral membrane (Zhang et al., 2003); it is conceivable that mutations
introduced to the MH domain might affect its association with the
membrane in ER after biosynthesis, and thus block the curving and
bending of the membrane during assembly. While the assembly and
budding of ﬂaviviral particles or VLPs from the ER membrane to the
lumen is believed to be a rapid process due to the lack of budding
intermediates clearly observed thus far (Ishak et al., 1988; Lindenbach
et al., 2007; Mackenzie and Westaway, 2001), future EM studies in
combinationwithblockingof vesicles budding fromERor trans-Golgi by
low temperature might provide morphological information regarding
how the MH domain is involved in the assembly (Beckers and Balch,
1989; Greenﬁeld et al., 1999).
In the infectivity assay of replicon particles, two of the three proline
mutants (I123P and V127P) at the C-terminus of the MH domain
affected entry. After the entry of DENV through receptor mediated
endocytosis, the low-pH environment in the endosome triggers a series
of conformational changes of E protein and fusion process, including the
hinge outward of domain II of E protein, lateral rearrangement of E
protein, exposure and insertion of the fusion loop of domain II into
endosomal membrane, trimerization of E protein, folding back of
domain III and the stem–anchor toward domain II, approximation of
membranes, and formation of fusion pore (Bressanelli et al., 2004; Liao
and Kielian, 2005; Lindenbach et al., 2007; Modis et al., 2004;
Mukhopadhyay et al., 2005; Zhang et al., 2004). The presence of a pre-
fusion intermediatewith exposed EH1 and EH2domainswas supported
by the observations that peptides derived from the stem as well as
recombinantdomain III,whichbound fusion intermediate, canblock the
fusion and by the recent capture of such intermediate using cryo-EM
Table 1
Adaptive codon changes in the prM gene of passage 0 and 5 viruses of mutants A120P, I123P and V127P.
Passage 0 virusesa Passage 5 virusesa Possible codon changes of the adapted residues in these mutants to other hydrophobic residuesb
Mutant A120P: j
P
P j
P
P
a j
P
P j
P
P
Residue 115, GGG (G)* aTGG (W) GGG (G) ATA (I), ATT (I), ATC (I)
Residue 120, CCA (P) aCTA (L)* CCA (P) GTG (V), GTA (V), GTT (V), GTC (V)
Mutant I123P: Mutant I123P: or TTT (F), TTC (F)
Residue 123, CCT (P)* aCTT (L) Residue 123, CCT (P) aCTT (L) CCT (P)
Mutant V127P: Mutant V127P: or ATG (M)
Residue 127, CCC (P)* aCTC (L) Residue 127, CCC (P) aCTC (L) CCC (P)
a BHK-21 cells were transfected with equal amounts ofWT and eachmutant genome-length RNA derived from a DENV2 infectious cDNA clone, and culture supernatants collected
on day 5 post-transfection of each mutant (passage 0 viruses) were continuously cultured on Vero cells for 5 rounds (5 days per round) to obtain the passage 5 viruses. Passage 0 and
5 viruses of eachmutant (A120P, I123P and V127P) were subjected to RNA extraction, RT-PCR and sequencing of the entire CprME genes. Adaptive codon changes were only found in
the prM gene and are presented. Parentheses indicate the amino acids with single letter designations, and single nucleotide changes are underlined. Asterisks indicate a minor
proportion based on the sequencing chromatograms in Fig. 5D.
b As a comparison, all the possible codon changes of the adapted residues in these mutants to other hydrophobic residues, including isoleucine, valine, phenylalanine, and
methionine are shown.
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Schmidt et al., 2010). Although how theM protein, which is believed to
locate in the “hole” between two E monomers with the MH domain
partially buried in the membrane, changes during the fusion process
remains unclear, it is likely that the MH domain also undergoes
considerable conformational change given that dramatic conformation-
al changes of the EH1 and EH2 domains occur from the membrane-
associated position to outward extension in the pre-fusion intermediate
and ﬁnally folding back to domain II. In this regard, our ﬁndings suggest
that disrupting the C-terminal helical structure of theMH domain could
affect the fusion process during virus entry. Alternatively, these two
mutants might affect entry by reducing the efﬁciency of prM cleavage,
though only sequences proximal to the cleavage site (residue 91) have
been reported to affect prM cleavage thus far (Junjhon et al., 2008;
Keelapang et al., 2004).
Comparison of the amino acid sequences of theMH domain among
different ﬂaviviruses revealed that the three residues, 120, 123 and
127, at the C-terminus of theMH domain are not absolutely conserved
by particular amino acids but are conserved by hydrophobic amino
acids, which is consistent with their location at the hydrophobic face
(a or d position) of the MH helical domain (Table 2). This feature is also
in agreement with the observed phenotypes of the mutants, in which
substitutions of alanine but not proline were somewhat tolerated
(Fig. 5A), and consistent with the adaptive changes, in which
substitutions to leucine, one of the hydrophobic residues, rather than
the original hydrophobic residue were found (Table 1). Interestingly,
there are nine residues in this region, which are adjacent to the residues
at the a or d position and are highly conserved by all four DENV
serotypes or all ﬂaviviruses, suggesting the structural or functional
importance of this domain. It should be noted that since proline
substitution greatly disrupted the helical structure, the phenotypes of
proline mutants in this study were attributed to the effect of structure
rather than the side chains of particular amino acids. Further studies
involving substitutions to alanine and other amino acids on these highly
conserved residues would better delineate their functional roles and
lead to the identiﬁcation of potential targets of anti-virals in the future.
Materials and methods
Plasmid constructs of VLPs
The prM/E expression constructs of DENV1 (pCB-D1), DENV2
(pCB-D2) and DENV4 (pCB-CD4) were described previously (Hu et al.,
2007). To generate the MH mutants of DENV4, a two-step PCR
mutagenesis was performed using pCB-D4 as template and the
primers (d4MS113PA2, d4MS113PB1, d4MA116PA2, d4MA116PB1,
d4MA120PA2, d4MA120PB1, d4MV123PA2, d4MV123PB1,
d4MI127PA2, d4MI127PB1, d4MS113AA2, d4MS113AB1,
d4MV123AA2, d4MV123AB1, d4MI127AA2, d4MI127AB1, d4KpnSS,and d4EBstEIIB2) as described previously (Hu et al., 2007). After the
second round PCR, the 950-bp product containing the MH mutation
was digested with KpnI/BstEII, and cloned into pCB-D4. To generate
the MH mutants of DENV1 and DENV2, a two-step PCR mutagenesis
was performed using pCB-D1 and pCB-D2 as templates, respectively,
and the primers (d1MI120PA2, d1MI120PB1, d1MV123PA2,
d1MV123PB1, d1MA127PA2, d1MA127PB1, d2MV120PA2,
d2MV120PB1, d2MI123PA2, d2MI123PB1, d2MI127PA2, and
d2MI127PB1). After the second round PCR, the 997-bp and 722-bp
products containing the MH mutations were digested with KpnI/
DraIII and KpnI/Bsu36I, and cloned into pCB-D1 and pCB-D2,
respectively. All the constructs were conﬁrmed by sequencing the
entire inserts to rule out second site mutations. The sequences of all
primers for mutagenesis will be provided upon request.Cell lysates, VLPs and Western blot analysis
293T cells prepared in a 10 cm-culture dish at 5×105 cells per dish
one day earlier were transfected with 10 μg of plasmid DNA by
calcium phosphate method (Hsieh et al., 2008). At 48 h post-
transfection, culture supernatants were collected (see below), and
cells were washed with PBS and treated with 1% NP40 lysis buffer
containing protease inhibitors (Roche Diagnostics), followed by
centrifugation at 20,000 ×g at 4 °C for 30 min to obtain cell lysates
(Hsieh et al., 2008). Culture supernatants were clariﬁed by centrifu-
gation at 1250 ×g for 20 min, ﬁltered through a 0.22 μm pore-sized
membrane (Sartorius), layered over a 20% sucrose buffer, and
ultracentrifuged at 65,000 ×g at 4 °C for 5 h to obtain pellets, which
were resuspended in 30 μl TNE buffer (Hsieh et al., 2008). ForWestern
blot analysis, cell lysates and pellets were subjected to 12% SDS-
polyacrylamide gel electrophoresis (PAGE), followed by transfer to
nitrocellulose membrane, blocking and incubation with primary
antibody, human serum from conﬁrmed dengue case or anti-calnexin
mouse Mab E-10 (Santa Cruz), and secondary antibody (Hsieh et al.,
2008; Wang et al., 2006). After ﬁnal washing, the signals were
detected by enhanced chemiluminescence reagents (Perkin Elmer life
sciences).Radioimmunoprecipitation
293T cells prepared in 6-well plate were transfected with plasmid
DNA by calcium phosphate method. At 20 h, the cells were washed,
incubated with methionine-free medium, followed by 50 Ci [35S]
methionine (Amersham Biosciences) at 37 °C for 6 h, and collected to
obtain cell lysates (Hsieh et al., 2008). Following pre-clear, cell lysates
were incubated with anti-E mouse Mab FL0232 (Chance Biotechnol-
ogy) at 4 °C overnight and then with protein A sepharose beads
(Amersham Biosciences) at 4 °C for 6 h. After washing, the beads were
Table 2
Comparison of amino acid sequences of the MH domain of prM protein of different
ﬂaviviruses.a
Virus Sequence
MH
11
3(
a)
12
0(
a)
12
3(
d)
12
7(
a)
11
6(
d)
DENV1
T R
R
V
VTR
A
AMSL
F
T R
VQ
N
V R
MSSEGAWKQIQKVETWALRH
MSSEGAWKHVQRIETWILRH
MSAEGAWRQVEKVETWALRH
MSSEGAWKHAQRVESWILRN
LDSTKATRYLMKTENWIIRN
MTGRMGERQLQKIERWLVRN
MDSTKATRYLVKIESWILRN
LEGDSLRTHLTRVEGWVWKN
* * ** * *
*
* * *
*
(n=90)
DENV2
(n=124)
DENV3
(n=105)
DENV4
(n=38)
JEV
(n=49)
YFV
(n=18)
WNV
(n=41)
TBEV
(n=21)
89
123
104 102
123 68 116
1 1
1
1
1
47
17
27
14 4 4 4
37 37 37
18
18
47 48
1
2
1
2 1
3
1 856
37
429
80 89 50
A
a
The MH domain of prM protein is an α-helical domain (Zhang et al., 2003).
Sequences of the MH domain of multiple strains of ﬂaviviruses were obtained
from GenBank and analyzed. Single letter designations of amino acid are shown
with the numbers above indicating amino acid positions and the numbers beneath
indicating the numbers of strains containing such residue. The residues at the a or d
position of the helical wheel are in bold. Asterisks indicate residues highly conserved
among the four DENV serotypes (*) or ﬂaviviruses (**) analyzed.
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was subjected to 12% SDS-PAGE (Hsieh et al., 2008).
Subcellular fractionation and enzyme digestion
293T cells transfected with plasmid DNA were washed 3 times
with PBS at 48 h, resuspended in modiﬁed buffer B (10% sucrose,
20 mM Tris, 150 mM NaCl, 10 mMMg acetate, and 1 mM EGTA [pH
7.6]), and frozen–thawed 8 times as described previously (Hsieh et al.,
2008; Xu et al., 1997). After clearing the nuclei and debris by
centrifugation at 1000 ×g for 5 min, the membrane fraction was
obtained by centrifugation at 20,000 ×g for 30 min at 4 °C. The
resulting supernatants were layered over a 20% sucrose buffer and
ultracentrifuged at 246,000 ×g at 4 °C for 1 h to obtain the pellets of
soluble fraction, which were resuspended in 30 μl TNE buffer (Hsieh
et al., 2008). Membrane fraction and pellets of soluble fraction were
subjected to Western blot analysis. Aliquots from above were treatedwith 500 U of endo-β-N-acetylglucosaminidase H (endo H) or peptide
N-glycosidase F (PNGase F) at 37 °C for 1 h according to the
manufacturer's instructions (New England Biolabs), and subjected
to Western blot analysis.
Infectious clone, replicon and CprME constructs
An infectious cDNA clone of DENV2 (pACYC FLTSV; strain TSV01)
and a subclone pACYC TSV-E were used to engineer mutations of the
MH domain in the context of genome-length RNA (Qing et al., 2010b).
The subclone pACYC TSV-E contains the SacII–XhoI fragment from the
pACYC FLTSV (spanning from T7 promoter to nucleotide position
5426 of the viral genome; GenBank accession number AY037116). A
QuikChange II XL site-directed mutagenesis kit (Stratagene) was used
to engineer MH mutations into the pACYC TSV-E. The mutated DNA
fragment was cut and cloned back into the pACYC FLTSV by the SacII
and BsrGI sites (nucleotide position 1840 of the genome). The DENV2
TSV01 Rluc2A replicon was constructed by replacing the structural
genes (CprME) with Renilla luciferase gene followed by FMDV 2A; the
coding sequences of 38 amino acids at the N-terminus of C protein and
31 amino acids at the C-terminus of E protein were retained to
preserve correct processing and translocation of NS1 as well as correct
topology of the remaining nonstructural polyprotein across the
membrane of ER. For replicon packaging constructs, the CprME-
coding fragment with Kozak sequence at the 5′-end and stop codon at
the 3′-end was cloned into pCR2.1-TOPO (Invitrogen); the resulting
plasmidwas used to engineerMHmutations by QuikChange II XL site-
directed mutagenesis kit; the mutated fragments were then cloned
into a Semliki forest virus (SFV) expression vector (Puig-Basagoiti
et al., 2005) through a unique XmaI site, resulting in the SFV–DENV2–
prME cDNA plasmid. All the constructs were veriﬁed by sequencing
the inserts and junctions.
In vitro transcription, RNA transfection, and immunoﬂuorescence assay
The genome-length RNA and replicon RNA were in vitro tran-
scribed from corresponding cDNA plasmids that were linearized with
ClaI. A T7 mMESSAGE mMACHINE kit (Ambion) was used for RNA
synthesis as described previously (Shi et al., 2002). The SFV–DENV2–
CprME RNA was in vitro transcribed from a linearized DNA
(predigested with the SapI) using an SP6 mMESSAGE mMACHINE
kit (Ambion). Both genome-length and replicon RNA were electro-
porated into BHK-21 cells (Shi et al., 2002). After transfection of
genome-length RNA, the cells were cultured at 37 °C for 24 h and then
at 30 °C; culture supernatants containing viruses were collected every
24 h until day 5, and were aliquoted and stored at −80 °C.
For the IFA, BHK-21 cells transfected with genome-length RNA
were seeded on a chamber slide (Nalge Nunc). At the indicated time
points, the cells were ﬁxed in 100% methanol at 4 °C for 30 min,
washed with PBS, and incubated with mouse anti-E Mab 4G2 at room
temperature for 1 h, followed by three washings with PBS and
incubation with Alexa Fluor 488 goat anti-mouse IgG at room
temperature for 1 h. After three washings with PBS and mounting
with DAPI, the slides were analyzed under a ﬂuorescence microscope
(Leica).
Replicon particle assays
Replicon particles of DENV2 were prepared by trans-supplying of
CprME proteins to replicon RNA as reported previously (Qing et al.,
2010a). Brieﬂy, 8×106 BHK-21 cells were electroporated with 10 μg of
DENV2 luciferase-reporting replicon RNA in a 0.4-cm cuvette with the
GenePulser apparatus (Bio-Rad) using the settings of 0.85 kV, 25 μF and
three pulsings at 3-s intervals. The transfected cellswere resuspended in
DMEM with 10% FBS, incubated at 37 °C for 24 h, and electroporated
again with 10 μg of SFV replicon RNA expressing WT or mutant CprME
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72 h post-ﬁrst transfection, culture supernatants were centrifuged to
remove cellular debris, and the supernatants containing replicon
particles were aliquoted and stored at −80 °C. To determine the RNA
copynumbers in the repliconparticles, repliconRNAwas extracted from
140 μl of supernatants and dissolved in 50 μl RNase free water, of which
5 μl was quantiﬁed by a real-time RT-PCR assay using primers targeting
the NS5 gene (5′-GAAGGAGAAGGGCTGCACA AAC-3′ and 5′-GCACACG-
CACCACCTTGTTTTG-3′) and the iScript™one-stepRT-PCRkitwith SYBR
Green (Bio-Rad). For replicon particle infection assay, Vero cells (4×104
cells perwell in 96-well plate) were infectedwith equal amounts ofWT
or mutant replicon particles (normalized by viral RNA copy numbers).
At the indicated time points, the cells were washed once with cold PBS,
lysed in 20 μl of 1× lysis buffer for 20 min, and assayed for luciferase
activities by using a Renilla luciferase assay kit (Promega) and a Clarity
luminescence microplate reader (BioTek).
Virion production from infectious clones
Twenty microliters of culture supernatants from genome-length
RNA-transfected BHK-21 cells on day 5 was centrifuged at 4000 ×g
and 4 °C for 30 min to remove the cell debris. The supernatants
(containing virions) were transferred to sterile Sorvall SS-34 tubes
and ultracentrifuged at 45,000 ×g and 4 °C for 1 h. After careful
removal of the supernatants, the pellets containing virions were
resuspended in 500 μl PBS; aliquots were dissolved in a sample buffer,
boiled for 5 min, and subjected to 5–12% SDS-PAGE and Western blot
analysis using mouse anti-E Mab 4G2 as described above. Viral RNA in
the pellets was quantiﬁed by real-time RT-PCR as described above.
Plaque assay, continuous passaging of mutants and adaptive mutations
Plaque assay in BHK-21 cells was performed as described previously
(Poh et al., 2009). Viruses collected on day 5 post-transfection (passage
0) of eachmutantwere continuously cultured on Vero cells for 5 rounds
(5 days per round) to obtain the passage 5 viruses. Viral RNA extracted
from culture supernatants of passage 0 and 5 viruses was subjected to
RT-PCR and sequencing of the entire CprME genes to examine the
adaptive mutations.
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